SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-041116
Filing Date
2022-02-14
Accepted
2022-02-14 14:09:57
Documents
3
Group Members
ANNE-MARI PASTERCLAUDIO NESSIOMEGA FUND VI GP MANAGER, LTD.OMEGA FUND VI GP, L.P.OTELLO STAMPACCHIA

Document Format Files

Seq Description Document Type Size
1 SC 13G d63577dsc13g.htm SC 13G 132092
2 EX-99.1 d63577dex991.htm EX-99.1 7192
3 EX-99.2 d63577dex992.htm EX-99.2 11149
  Complete submission text file 0001193125-22-041116.txt   152097
Mailing Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 329 OYSTER POINT BLVD., 3RD FLOOR SOUTH SAN FRANCISCO CA 94080 650 325 5156
Imago BioSciences, Inc. (Subject) CIK: 0001623715 (see all company filings)

IRS No.: 454915810 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92697 | Film No.: 22629349
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199
Business Address 888 BOYLSTON ST., SUITE 1111 BOSTON MA 02199 617-502-6538
Omega Fund VI, L.P. (Filed by) CIK: 0001757917 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G